Published in J Natl Cancer Inst on December 03, 1997
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10. J Clin Oncol (2009) 2.08
A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood (2013) 1.64
Health status of adolescent and young adult cancer survivors. Cancer (2012) 1.44
Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer (1998) 1.31
Smoking cessation: an integral part of lung cancer treatment. Oncology (2010) 1.16
Epidemiology of lung cancer prognosis: quantity and quality of life. Methods Mol Biol (2009) 1.14
Patient-provider communication and perspectives on smoking cessation and relapse in the oncology setting. Patient Educ Couns (2009) 1.11
Smoking and ethics: what are the duties of oncologists? Oncologist (2010) 1.06
Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer (2011) 1.05
Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers. Nicotine Tob Res (2012) 1.00
Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract (2009) 0.97
Thymoma and multiple malignancies: a case of five synchronous neoplasms and literature review. Clin Med Res (2003) 0.95
A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol (2011) 0.93
Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol (2014) 0.91
Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin (2014) 0.90
Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology (2012) 0.90
Health behaviors of early-stage non-small cell lung cancer survivors. J Cancer Surviv (2011) 0.86
Health behaviors, readiness to change, and interest in health promotion programs among smokers with lung cancer and their family members: a pilot study. Cancer Nurs (2013) 0.85
Disparities between blacks and whites in tobacco and lung cancer treatment. Oncologist (2011) 0.83
Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992-2008. Cancer Causes Control (2012) 0.83
Pathological confirmation of primary lung cancer following breast cancer. Lung Cancer (2009) 0.82
Survival after treatment of small-cell lung cancer: an endless uphill battle. J Natl Cancer Inst (1997) 0.81
Harm reduction and cessation efforts and interest in cessation resources among survivors of smoking-related cancers. J Cancer Surviv (2013) 0.81
Eight ways to stay healthy after cancer: an evidence-based message. Cancer Causes Control (2013) 0.79
Impact of postdiagnosis smoking on long-term survival of cancer patients: the Shanghai cohort study. Cancer Epidemiol Biomarkers Prev (2013) 0.77
Integrating tobacco treatment into thoracic oncology settings: Lessons learned. J Health Psychol (2015) 0.76
Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial. Contemp Clin Trials (2016) 0.75
Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity. Curr Oncol (2016) 0.75
Exploring Issues of Comorbid Conditions in People Who Smoke. Nicotine Tob Res (2016) 0.75
Perceptions and practices of Japanese nurses regarding tobacco intervention for cancer patients. J Epidemiol (2011) 0.75
Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med (1999) 5.84
The Brown and Williamson documents. Where do we go from here? JAMA (1995) 5.16
A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med (1992) 5.10
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med (1999) 4.81
A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med (2000) 4.54
Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol (2000) 4.10
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist (2000) 3.62
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol (1999) 3.48
A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience (2005) 3.41
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys (1994) 3.29
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol (1997) 3.27
NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl (1996) 3.24
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet (2010) 3.21
Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev (1996) 3.06
The relationship between spike rate and synchrony in responses of auditory-nerve fibers to single tones. J Acoust Soc Am (1980) 3.02
The brown protein of Drosophila melanogaster is similar to the white protein and to components of active transport complexes. Mol Cell Biol (1988) 2.98
A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer. J Natl Cancer Inst (2000) 2.95
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. J Clin Oncol (1988) 2.91
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med (1989) 2.81
Validity of sexual histories in a prospective study of male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.81
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol (2001) 2.73
Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery (1989) 2.66
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (1987) 2.59
Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med (1977) 2.52
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer. Ann Oncol (2012) 2.38
Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet (1981) 2.36
Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs. Arch Intern Med (1993) 2.36
An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature (1997) 2.29
The probability of blindness from open-angle glaucoma. Ophthalmology (1998) 2.28
Effect of preemptive multimodal analgesia for arthroscopic knee ligament repair. Reg Anesth Pain Med (2001) 2.26
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A (1998) 2.20
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group. Ann Intern Med (1996) 2.15
1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14
Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res (1992) 2.09
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med (2000) 2.07
Lung cancer complicating pregnancy: case report and review of literature. Mayo Clin Proc (1995) 2.06
Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.05
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Identification of overlapping DNA-binding and centromere-targeting domains in the human kinetochore protein CENP-C. Mol Cell Biol (1996) 1.99
Probability of filtration surgery in patients with open-angle glaucoma. Arch Ophthalmol (1999) 1.98
IA-1, a new marker for neuroendocrine differentiation in human lung cancer cell lines. Cancer Res (1993) 1.96
Tanning with ultraviolet A sunbeds. BMJ (1990) 1.93
Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med (1986) 1.90
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol (1990) 1.88
NY-ESO-1 may be a potential target for lung cancer immunotherapy. Cancer J Sci Am (1999) 1.86
Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med (1987) 1.85
Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst (1995) 1.83
Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies. J Clin Oncol (1984) 1.80
Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med (1979) 1.79
Tanning, protection against sunburn and vitamin D formation with a UV-A 'sun-bed'. Br J Dermatol (1982) 1.79
Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol (1999) 1.77
Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol (1992) 1.77
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. J Clin Oncol (1986) 1.76
Obesity and therapy-related toxicity in patients treated for small-cell lung cancer. J Natl Cancer Inst (1995) 1.76
Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group. Ann Intern Med (1994) 1.73
Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival. J Natl Cancer Inst (1993) 1.73
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol (1989) 1.69
Characteristics of cell lines established from human colorectal carcinoma. Cancer Res (1987) 1.69
Neural tube defects in hurricane aftermath. Lancet (1991) 1.69
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors. Ann Oncol (2009) 1.68
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol (1986) 1.67
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med (1993) 1.66
Cancer incidence among Canadian kidney transplant recipients. Am J Transplant (2007) 1.66
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys (1997) 1.65
Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol (1985) 1.64
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg (1995) 1.63
RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol (1996) 1.63
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res (1992) 1.61
Clinical pharmacology of sisomicin. Antimicrob Agents Chemother (1975) 1.61
A forty-year review of bacterial endocarditis in infancy and childhood. Circulation (1975) 1.60
The reliability of sexual histories in AIDS-related research: evaluation of an interview-administered questionnaire. Can J Public Health (1987) 1.60
Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg (2001) 1.60
Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol (1999) 1.58
Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. J Clin Oncol (2001) 1.58
MDR1 gene expression in lung cancer. J Natl Cancer Inst (1989) 1.57
Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys (1996) 1.56
Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg (1993) 1.55
Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol (1993) 1.54
The curve of Spee revisited. Am J Orthod Dentofacial Orthop (1996) 1.54
Mycobacteriosis in patients with malignant disease. Arch Intern Med (1976) 1.54
Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol (1996) 1.53
Gemcitabine: single-agent and combination therapy in non-small cell lung cancer. Oncologist (1999) 1.53
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol (1984) 1.51
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg (2000) 1.50
Characteristics of cell lines established from human gastric carcinoma. Cancer Res (1990) 1.49